Polyene phosphatidylcholine enhances the therapeutic response of oxaliplatin in gastric cancer through Nrf2/HMOX1 mediated ferroptosis
In conclusion, our study reveals the synergistic antitumour potential of PPC and OXA while protecting patients against hepatic injury. This suggests a promising combined treatment approach for patients with advanced gastric cancer.PMID:38377934 | DOI:10.1016/j.tranon.2024.101911
Source: Translational Oncology - Category: Cancer & Oncology Authors: Peijie Lei Lianjing Cao Hongjun Zhang Jialei Fu Xiaojuan Wei Fei Zhou Jingjing Cheng Jie Ming Haijun Lu Tao Jiang Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Study | Translocation